Category: Cannabis Stocks
Cronos Reports Improved Financials For Q1-2025 As Demand Outpaces Supply
Cronos reports strong Q1-2025 performance with rising sales, but faces Israeli tariff risks. Read why CRON is a Hold even…
Hedge Fund Veteran Doug Kass Says Most Cannabis Stocks Are ‘Walking Dead,’ But These 4 Names Stand Out
Doug Kass says most cannabis stocks are ‘walking dead’ — but highlights Trulieve, GTI, TerrAscend and Glass House as top…
5 Undervalued Pharmaceuticals Stocks for Thursday, May 15
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top…
World’s Largest Tobacco Company Is Investing In Medical Cannabis: Here’s What To Know
Philip Morris is expanding its medical cannabis strategy via Aurora and Avicanna. What it means for the future of Big…
This Cannabis Stock Sits Out The Rally Sparked By US-China Deal
A trade deal between the U.S. and China lit a fire under U.S.-traded Chinese stocks on Monday, but this cannabis…
2 Stocks Near Their 52-Week Lows That Still Aren’t Worth Buying
In Q4, Elevidys’ revenue declined by about 2% year over year. Sarepta Therapeutics might have to deal with this issue…
SA Asks: What are the best cannabis stocks right now?
What are the most attractive cannabis stocks right now for investors? Seeking Alpha analysts offer their picks. Read more here.
Trulieve Cannabis is a buy, Beacon says
Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and C$11.00 price target in a May 8 note.
This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forward
Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expansion plays.
1 Beaten-Down Stock-Split Company to Avoid in 2025 and Beyond
Tilray has a proposed reverse stock split on the table that will help it avoid getting delisted from the Nasdaq….
Recent Comments